Old Web
English
Sign In
Acemap
>
Paper
>
Sa1086 Adalimumab or Infliximab for the Treatment of Inflammatory Bowel Disease Patients: Which Is More Effective?
Sa1086 Adalimumab or Infliximab for the Treatment of Inflammatory Bowel Disease Patients: Which Is More Effective?
2014
Maria Jesus Carrillo-Ramos
Calixto Duarte Chang
Belen Maldonado-Perez
Rocío Beltrán Castaño
Luisa Castro Laria
Federico Argüelles-Arias
Antonio Benitez-Roldan
Angel Caunedo-Alvarez
Francisco Pellicer-Bautista
Juan Manuel Herrerias
Keywords:
General surgery
Infliximab
Adalimumab
Inflammatory bowel disease
Medicine
Diabetes mellitus
Gastroenterology
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]